Intravenous immunoglobulin, HLA allele typing and HLAMatchmaker facilitate successful transplantation in highly sensitized pediatric renal allograft recipients

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Pediatric Transplantation

• Publication date

  2007-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1399-3046.2006.00617.xPMID 17239127
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predictive value of human leucocyte antigen epitope matching using HLAMatchmaker for graft outcomes in a predominantly African‐American renal transplant cohort

  2006cited by this paper
• Extending options for highly sensitized patients to receive a suitable kidney graft.

  2005cited by this paper
• Is the application of HLAMatchmaker relevant in kidney transplantation?

  2005cited by this paper
• Differential immunogenicity of HLA mismatches in clinical transplantation.

  2005cited by this paper
• HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates

  2004cited by this paper
• Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

  2004cited by this paper
• Beneficial effect of matching at the HLA-A and -B amino-acid triplet level on rejection-free clear graft survival in penetrating keratoplasty1

  2004cited by this paper
• Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantation

  2004cited by this paper
• HLA matching for kidney transplantation.

  2004cited by this paper
• DACLIZUMAB VERSUS NO INDUCTION THERAPY, IN COMBINATION WITH CYCLOSPORINE MICROEMULSION, MYCOPHENOLATE MOFETIL, AND CORTICOSTEROIDS, IS ASSOCIATED WITH DECREASED ACUTE REJECTION IN CARDIAC TRANSPLANT RECIPIENTS AND NO OBSERVED INCREASE IN MORTALITY.

  2004cited by this paper
• The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome.

  2004cited by this paper
• HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival1

  2003cited by this paper
• HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increas the number of compatible donors for highly sensitized patients1

  2003cited by this paper
• HLA MATCHMAKER: A MOLECULARLY BASED ALGORITHM FOR HISTOCOMPATIBILITY DETERMINATION

  2003cited by this paper
• Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients1

  2003cited by this paper
• Intravenous immunoglobulin increases risk of thrombotic events

  2002cited by this paper
• Successful renal transplant outcome after intravenous gamma‐globulin treatment of a highly sensitized pediatric recipient

  2002cited by this paper
• The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients.

  2002cited by this paper
• Desensitization and Subsequent Kidney Transplantation of Patients Using Intravenous Immunoglobulins (IVIg)

  2002cited by this paper
• HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm.

  2002cited by this paper
• PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE RECIPIENTS

  2000cited by this paper
• Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation.

  1996cited by this paper
• High‐dose intravenous immunoglobulin and serum viscosity

  1994cited by this paper
• Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ.

  1994cited by this paper
• SUPPRESSION OF HLA‐SPECIFIC ALLOANTIBODIES BY HIGH‐DOSE INTRAVENOUS IMMUNOGLOBULINS (IVIg): A POTENTIAL TOOL FOR TRANSPLANTATION OF IMMUNIZED PATIENTS

  1993cited by this paper
• Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation.

  1989cited by this paper
• Renal transplantation after removal and prevention of resynthesis of HLA antibodies.

  1984cited by this paper

• Challenges Surrounding Induction Protocols in Children

  2021cites this paper
• Desensitisation strategies in high-risk children before kidney transplantation

  2018cites this paper
• Pediatric kidney transplantation: a historical review

  2017cites this paper
• HLAMatchmaker is effective for selecting appropriate platelet units for alloimmunised thrombocytopaenic patients who are refractory to random donor platelets

  2017cites this paper
• Are We Ready for Epitope-Based HLA Matching in Clinical Organ Transplantation?

  2017cites this paper
• Management of sensitized pediatric patients prior to renal transplantation

  2016cites this paper
• Application of an epitope‐based allocation system in pediatric kidney transplantation

  2016cites this paper
• Increasing Kidney Transplant Availability: Live Donation, Paired Donation, and Transplant Across ABO and HLA Barriers

  2016cites this paper
• Le rejet humoral aigu en transplantation rénale pédiatrique

  2016cites this paper
• Antibody-mediated rejection

  2015cites this paper
• ABO-incompatible, paired kidney exchange transplantation in a highly sensitized patient with donor-specific antibodies

  2015cites this paper
• Biologics in renal transplantation

  2014cites this paper
• HLA epitope based matching for transplantation.

  2014cites this paper
• Issues in solid-organ transplantation in children: translational research from bench to bedside

  2014cites this paper
• HLA matching at the epitope level: the way to go.

  2013cites this paper
• Pediatric kidney transplantation: a review

  2013cites this paper
• Treatment update of sensitized pediatric kidney transplant recipients: a review.

  2012cites this paper
• EpHLA software: a timesaving and accurate tool for improving identification of acceptable mismatches for clinical purposes.

  2012cites this paper
• Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications.

  2011cites this paper
• Human Leukocyte Antigen

  2011cites this paper
• EpHLA: an innovative and user-friendly software automating the HLAMatchmaker algorithm for antibody analysis.

  2011cites this paper
• Evaluation of HLA Matchmaker compatibility as predictor of graft survival and presence of Anti-HLA antibodies.

  2010cites this paper
• Why can sensitization by an HLA-DR2 mismatch lead to antibodies that react also with HLA-DR1?

  2009cites this paper
• Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.

  2009cites this paper
• HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies

  2009cites this paper
• Clinical Evaluation of Alloantibodies in Solid Organ Transplantation

  2009cites this paper
• Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions

  2008cites this paper
• Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation.

  2008cites this paper
• New trends in immunosuppression for pediatric renal transplant recipients

  2007cites this paper
• Update on HLAMatchmaker: a Molecularly Based Algorithm for Histocompatibility Determination at the Epitope Level

  2007cites this paper
• Organ sharing in Saudi Arabia: a proposal.

  2007cites this paper
• IN PRESS hy can sensitization by an HLA-DR 2 mismatch lead to antibodies that react lso with HLA-DR 1 ?

  year unknowncites this paper